Doses to the hand during the administration of radiolabeled antibodies containing Y-90, Tc-99m, I-131, and Lu-177
- Minnesota Univ., Minneapolis, MN (United States). School of Public Health
- Brookhaven National Lab., Upton, NY (United States)
Exposure of the hands of medical personnel administering radiolabeled antibodies (RABs) was evaluated on the basis of (a) observing and photo-documenting administration techniques, and (b) experimental data on doses to thermoluminescent dosimeters (TLDs) on fingers of phantom hands holding syringes, and on syringes, with radionuclides in the syringes in each case. Actual exposure data for I-131 and Lu-177 were obtained in field studies. Variations in handling and administration techniques were identified. Dose rates measured using TLDs on the surface of loaded syringes were adjusted for differences in electronic stopping power, absorption coefficients, and attenuation between dosimeters and tissue to estimate dose-to-skin averaged over 1 cm{sup 2} at 7 mg cm{sup {minus}2} depth for Y-90, Tc-99m, I-131, and Lu-177. Dose rate coefficients to the skin, if in contact with the syringe wall, were 89, 1.9, 3.8, and 0.41 {micro}Sv s{sup {minus}1} per 37 MBq (1 mCi) for Y-90, Tc-99m, I-131, and Lu-177, respectively. For dose reduction, when using Y-90 the importance was clearly indicated of (a) avoiding direct contact with syringes containing RABs, if practical, and (b) using a beta-particle shield on the syringe. In using a syringe for injection, doses can best be approximated for the geometry studied by (a) wearing a finger dosimeter on the middle finger, toward the outside of the hand, on the hand operating the plunger, and (b) wearing finger dosimeters on the inner (palm) side of the finger on the hand that supports the syringe for energetic beta-particle emitters, such as Y-90 and Re-188.
- Research Organization:
- US Nuclear Regulatory Commission (NRC), Washington, DC (United States). Div. of Regulatory Applications; Minnesota Univ., Minneapolis, MN (United States). School of Public Health; Brookhaven National Lab. (BNL), Upton, NY (United States)
- Sponsoring Organization:
- Nuclear Regulatory Commission, Washington, DC (United States)
- DOE Contract Number:
- AC02-76CH00016
- OSTI ID:
- 446333
- Report Number(s):
- NUREG/CR-6493; BNL-NUREG-52510; ON: TI97004343; TRN: 97:006494
- Resource Relation:
- Other Information: PBD: Feb 1997
- Country of Publication:
- United States
- Language:
- English
Similar Records
Survey of radiopharmaceutical use and safety in sixty-nine hospitals
Comparison of internal dose estimates obtained using organ-level, voxel S value, and Monte Carlo techniques